How can a constitutively active 'master' kinase with numerous downstream targets preferentially phosphorylate one or more of these without influencing all simultaneously? How might such a system be switched off? The characterization of the role of deubiquitination in regulating the phosphorylation and activation of AMPK (AMP-activated protein kinase)-related kinases by LKB1 suggests a novel and interesting mechanism for conferring signal transduction specificity and control at the kinase substrate level. In this issue of the Biochemical Journal, Al-Hakim et al. show that the AMPK-related kinases NUAK1 (AMPKrelated kinase 5) and MARK4 (microtubule-affinity-regulating kinase 4) are polyubiquitinated in vivo and that they serve as substrates of the deubiquitinating enzyme USP9X; furthermore, the first evidence is provided for regulation of AMPK-related kinase family members mediated via unusual Lys 29 /Lys 33 polyubiquitin chains, rather than the more common Lys 48 /Lys 63 linkages.
The serine/threonine kinase LKB1 was first identified as a tumour-suppressor protein [1] . Mutation of LKB1 is linked to Peutz-Jehgers syndrome, a disease characterized by the development of intestinal hamartomas and an increased risk for the development of malignant cancers in various tissues. Understanding of LKB1's functional role was broadened by the discovery that it phosphorylates and activates AMPK (AMPactivated protein kinase)-related kinases [1] . Of 22 AMPK family members, 14 are activated by LKB1 through phosphorylation of their T-loop threonine residues. These include the catalytic subunits of AMPK itself (AMPK α 1 and α 2 ), BRSK1 and 2 (brain-specific kinases 1 and 2), MARK1-4 (microtubule-affinityregulating kinases 1-4), NUAK1/ARK5 (AMPK-related kinase 5), NUAK2/SNARK [SNF1 (sucrose-non-fermenting)/AMPKrelated kinase], QIK (Qin-induced kinase), QSK, SIK (saltinduced kinase) and SNRK (SNF-related kinase). The primary function of AMPK in regulating cellular metabolism has been characterized extensively, and emerging roles for AMPK in other cellular processes appears to follow the metabolism paradigm [2, 3] . In contrast, the functions of the other AMPK-related kinases are less well defined.
Since LKB1 activates a number of kinases in the AMPKrelated kinase family, how is signal specificity and context generated? Interestingly, LKB1 is generally considered to be constitutively active [1] [2] [3] , despite observed phosphorylation on several sites [1] . Clearly, specification of LKB1 signalling must occur at the level of LKB1 substrates. Several mechanisms probably influence the outcome of LKB1 signalling. Regulated expression of individual LKB1 targets could restrict or expand LKB1 signalling through those specific pathways. Cofactors may be required to expose sites for LKB1 phosphorylation or to make these sites less susceptible to the action of phosphatases. Such is the case for AMPK, where AMP displaces ATP from binding sites on the non-catalytic γ -subunit of AMPK, causing a conformational shift in the heterotrimeric AMPK that results in increased phosphorylation [2, 3] . In this case, it appears that binding of AMP to the γ -subunit renders the complex a poorer substrate for protein phosphatase 2C. Protein localization and post-translational modifications could also contribute to LKB1 target accessibility and allow specificity of LKB1 signalling. One post-translational modification, ubiquitination, is addressed in this Commentary.
UBIQUITINATION OF PROTEINS IN CELLULAR REGULATION
Protein ubiquitination was first described as a mechanism for targeting proteins for rapid proteasomal degradation [4] . Since then, additional roles for ubiquitination in chromatin remodelling and endocytosis have been described, although connections to other biological processes have been suggested [5] .
Ubiquitin is attached covalently to target proteins in a series of reactions driven by ubiquitin ligases [4] . E1 ligases load ubiquitin onto E2 ligases, which in turn modify target proteins [4] . Substrate specificity is generated by E3 proteins, which serve as substrate adaptors for E2 machinery [4] . Ubiquitination of substrate proteins occurs via lysine residues, often at multiple sites [4] . Monoubiquitination results in recruitment of ubiquitin-binding proteins that can drive non-destructive functions, including endocytosis and chromatin remodelling [5] , as well as polyubiquitination by E4 ubiquitin ligases. E4 ligases convert initial monoubiquitin modifications into polyubiquitin chains. Chain formation can occur through distinct lysine residues in ubiquitin itself, allowing the formation of unbranched and branched structures. Although polyubiquitination can occur through seven lysine residues, ubiquitination at Lys 48 and Lys 63 are best defined. Polyubiquitination via Lys 48 of ubiquitin results in targeting to the proteasome for degradation. Polyubiquitination via Lys 63 results in a distinct three-dimensional structure that alters protein function and does not result in protein degradation at the proteasome [5, 6] . Less is known about lysine chains that are conjugated through other lysine residues in ubiquitin.
Although not as abundant as E3 enzymes, a large number of DUBs (deubiquitinating enzymes) have been identified. DUBs are metallo-or cysteine proteases that fall into five families: UCHs (ubiquitin C-terminal hydrolases), USPs (ubiquitinspecific proteases), MJDs (Machado-Joseph disease protein domain proteases), OTUs (ovarian tumour proteases), and JAMM motif proteases [7] . Of these, USPs are the most diverse and abundant. Several DUBs are associated with ubiquitin recycling during protein degradation at the proteasome, whereas the vast majority play different roles in the cell [7] . A number of DUBs associate with E3 enzymes [7] , perhaps acting as a control mechanism to ensure that proper ubiquitin chain formation is achieved.
A role for ubiquitin in controlling signal transduction has been demonstrated [5] . NFκB (nuclear factor κB) signal transduction was shown to be altered by ubiquitin-mediated degradation of pathway components [5] . However, Lys 63 -linked polyubiquitination of TRAF-6 (tumour-necrosis-factorreceptor-associated factor 6) resulted in its activation and downstream phosphorylation of TAK1 (transforming growth factor-β-activated kinase 1), an effect that is independent of ubiquitin-mediated protein degradation [8] .
UBIQUITINATION AS A POSSIBLE MECHANISM FOR SELECTIVITY OF PHOSPHORYLATION OF AMPK-RELATED KINASES BY LKB1
In this issue of the Biochemical Journal, Al-Hakim et al. [9] describe a novel function for protein ubiquitination in regulating LKB1 signal transduction in a manner independent of protein degradation. Consistent with ubiquitination playing a role in LKB1 substrate specification, the ability of LKB1 to phosphorylate and activate some of the AMPK-related kinases is dependent upon their ubiquitin modification status. Several AMPK family member proteins are ubiquitinated in vivo, namely AMPKα1, BRSK1, MARK3, MARK4, NUAK1 and, to a lesser extent, NUAK2 and MARK1 [9] . Polyubiquitination occurred through Lys 29 and Lys 33 of ubiquitin, and did not appear to result in protein degradation [9] . Furthermore, the deubiquitinating enzyme USP9X was found to associate with MARK4 and NUAK1 in pull-down assays, and was also found to cleave polyubiquitin chains from NUAK1 in vitro in a manner that required the USP9X-NUAK1 interaction [9] . Importantly, polyubiquitination of MARK4 and NUAK1 made these kinases refractory to phosphorylation and activation by LKB1 in vitro [9] . Al-Hakim et al. propose a conformational regulatory system for controlling the activity of AMPK-related kinases, whereby the kinase domain and conjugated Lys 29 /Lys 33 polyubiquitin chains compete for the UBA (ubiquitin-associated) domain [9] . UBA domain binding to the kinase domain is required for activation of several AMPKrelated kinases by LKB1 [10] ; competition for UBA domain binding by an attached polyubiquitin chain would be expected to block activation. While the UBA domain has shown a limited ability to bind ubiquitin, it should be noted that a polyubiquitin chain covalently bound near the UBA domain would raise the local ubiquitin concentration to a level that could 'force' a normally weak interaction. Deubiquitination by USP9X or other DUBs would result in the release of this autoinhibitory interaction, exposure of LKB1 target phosphorylation sites, and subsequent LKB1 phosphorylation that would drive activation of the kinase.
The observations that other members of this family are also polyubiquitinated on Lys 29 /Lys 33 chains [9] and contain a UBA domain or a UBA-like motif suggest that the proposed conformational mechanism for NUAK1/MARK4 regulation could represent a paradigm for regulation of many members of the AMPK-related kinase family. In our view, it appears that regulation of both the polyubiquitination of these kinases by specific E3 enzymes and their deubiquitination by specific DUBs allows the cell to make a specific fraction of each AMPK-related kinase conformationally susceptible to phosphorylation by LKB1. Thus, for NUAK1 and MARK4, susceptibility to phosphorylation could be increased by activation of USP9X and decreased by activation of an as yet unidentified E3. The specificity of USP9X for MARK4 and NUAK1 binding [9] suggests that other DUBs mediate deubiquitination of other members of the AMPKrelated kinase family. In this case, switching off the inactivation mechanism by DUBs of high specificity probably results in the ability of LKB1 to phosphorylate and activate only a few of its possible substrates. Such a model is appealing for its ability to allow the cell to make decisions about different outcomes of LKB1 signalling. Thus LKB1 signalling could be tailored to fit specific cellular or physiological contexts.
FUTURE DIRECTIONS
A complete inventory of ubiquitin ligases and DUBs that recognize AMPK-related kinases will be critical in understanding the LKB1 signalling network. However, a more fundamental question remains poorly understood. How is the activity of USP9X controlled? Al-Hakim et al. [9] demonstrate convincingly that many AMPK-related kinases are present in a polyubiquitinated form in cells. These polyubiquitin chains are removed when the cytosol is not treated with NEM (N-ethylmaleimide) or, in the case of NUAK1, when USP9X is added [9] . Clearly, deubiquitination in the cell is being actively prevented by an unknown mechanism. Whether USP9X, as well as other as yet unidentified ubiquitin modification systems that recognize AMPK-related kinases, is regulated by expression, post-translational modifications, localization or availability remains to be elucidated. The concepts elucidated by these studies may be applicable to many signal transduction pathways in the cell. We eagerly anticipate forthcoming work that will characterize how ubiquitination may function to regulate LKB1, an important signalling nexus.
